Its vital for patients to know compounded drugs are not FDA-approved medicines, Jones said
10.1016/j.tem.2015.12.004 22 PaolettiP.BelloneC.ZhouQ
Tirzepatide : $400-$975 for monthly supply of treatment, price depends on exact dosage that patients titrate up to
Additionally, it strengthens the immune system, providing better protection against illnesses
Many customers commend the company's professionalism, efficiency, and commitment to patient-centered care
This approval, based on the positive results from the SURMOUNT-CN clinical trial, makes tirzepatide the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for obesity treatment in China, which is expected to enhance its market positioning in the country, says GlobalData